Investigation of Teladoc Health Inc.

Teladoc Health, Inc. TDOC Officers and Directors Accused of Failing to Disclose Conduct Violations to Investors

According to the filed complaint against the company’s officers and directors for breaches of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and violations of the Securities Exchange Act of 1934 between March 3, 2016 and the present, Teladoc Health, Inc. TDOC executives allowed multiple violations that hurt the company, including an inappropriate relationship between an executive and lower-level employee, insider trading, harassment of the Company’s employees, and retaliation against a whistleblower. Teladoc executives breached their fiduciary duties by misleading shareholders through materially false statements that failed to disclose this inappropriate activity and their lack of enforcement of Teladoc’s conduct policies. In December 2018, Southern Investigative Reporting Foundation published an article that revealed all of Teladoc executives’ violations. On this news, Teladoc stock fell $4.00, over 6.5%, to close at $55.81. As a result of their materially false and misleading statements, the CEO and CFO have been named as defendants in a securities fraud class action lawsuit that Teladoc is required to defend, further injuring shareholders.

If you are a former employee of Teladoc Health, Inc. TDOC and own stock, please contact us for more information about your rights and potential remedies.

Send us a message for more information.

Protect your investments.

Sign up for free investment monitoring.

Stock Watch members receive free investment monitoring and notifications.  

Leave your details to get started

"*" indicates required fields

Ticker + Amount
This field is for validation purposes and should be left unchanged.

Skip to content